Gilead Sciences (GILD) debt: $24.9B
Gilead Sciences had $24.9B of long-term debt on Dec 31, 2025, including the part due within a year, down 6.6% from $26.7B a year earlier.
From Gilead Sciences's filings with the SEC · Read the filing · GILD stock page
Gilead Sciences debt by year
#68 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 31, 2025 | $24.9B | -7% |
| Dec 31, 2024 | $26.7B | +7% |
| Dec 31, 2023 | $25B | -1% |
| Dec 31, 2022 | $25.2B | -5% |
| Dec 31, 2021 | $26.7B | – |
Debt of similar companies
Companies in the same industry as Gilead Sciences, by SEC industry code, with the closest debt. Each name opens the same page for that company.
Questions and answers
What is Gilead Sciences's debt?
Gilead Sciences had $24.9B of long-term debt on Dec 31, 2025, including the part due within a year, down 6.6% from $26.7B a year earlier.
Numbers as reported in Gilead Sciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology